Washington D.C., Sep 25, 2018 / 13:45 pm
The Department of Health and Human Services has announced the termination of a contract between the Food and Drug Administration and Advanced Bioscience Resources, Inc. The news comes after members of Congress and pro-life advocates expressed concern about the research goals of the experiment.
The announcement was made Sept. 24 in a statement posted on the HHS departmental website.
"After a recent review of a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements," the statement read.
"As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations."